You are here

  • Home
  • Archive
  • Volume 33, Issue Suppl 4
  • PO003/#269  Ignite: a phase II signal-seeking trial of adavosertib targeting recurrent high grade serous ovarian cancer with cyclin E1 over-expression with and without gene amplification

Citation Tools

Article menu

Download PDFPDF

Plenary 01: Oral Abstract Presentations
AS11. Ovarian cancer
PO003/#269  Ignite: a phase II signal-seeking trial of adavosertib targeting recurrent high grade serous ovarian cancer with cyclin E1 over-expression with and without gene amplification
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Au-Yeung G, Bressel M, Prall O, et al
PO003/#269  Ignite: a phase II signal-seeking trial of adavosertib targeting recurrent high grade serous ovarian cancer with cyclin E1 over-expression with and without gene amplification
International Journal of Gynecologic Cancer 2023;33:A2-A3.